Human Health Division (HHD) Products

Product List by Brand Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Allertin

Composition
Allertin 20 Tablet: Each tablet contains Bilastine INN 20 mg.
Allertin ODT 10: Each orally disintegrating tablet contains Bilastine INN 10 mg.
Allertin Oral Solution: Each ml oral solution contains Bilastine INN 2.5 mg.

Indication
Seasonal Allergic Rhinitis: Bilastine is indicated for the symptomatic relief of nasal and non-nasal symptoms  of seasonal allergic rhinitis (SAR) in patients of 4 years and older.
Chronic Spontaneous Urticaria: Bilastine is indicated for the relief of the symptoms associated with chronic spontaneous urticaria (CSU) (e.g. pruritus and hives), in patients of 4 years of age and older.

Dosage & Administration
Allertin 20 Tablet: Adults and adolescents 12 years of age and above: 20 mg tablet once daily. The tablet should be taken one hour before or two hours after intake of food.
Allertin Oral Solution: 4 ml of oral solution once daily for children 4 to 11 years of age. Recently, it has been approved in Latin America for children from 2 years of age. The oral solution should be taken one hour before or two hours after intake of food or fruit juice. Allertin ODT 10: The maximum recommended daily dose for children in
between 4 to 11 years is 10 mg Bilastine orally disintegrating tablet (1 tablet)  and  should  not  be  exceed.  If  a  dose  is  missed,  the  next scheduled dose should be taken. An extra dose is not necessary or as directed by the physician.

Alleloc

Description
Olopatadine selectively blocks histamine H1 receptor and
stabilizes mast cells. Thus it prevents histamine binding to its
receptors and inhibits mast cell degranulation & histamine
release.
Composition
AllelocSterile Eye Drops: Each ml contains Olopatadine
Hydrochloride USP equivalent to Olopatadine 1 mg.
AllelocDS Sterile Eye Drops: Each ml contains Olopatadine
Hydrochloride USP equivalent to Olopatadine 2 mg.
Indications
Allergic conjunctivitis.
Dosage and administration
Alleloc™: Instill one drop in the affected eye (s) twice daily or as
directed by the physician.
AllelocDS: Instill one drop in the affected eye (s) once daily
or as directed by the physician.
Side effects
Mild transient burning or stinging, blurred vision, cold syndrome,
foreign body sensation, hyperaemia, headache and pharyngitis.
Precautions
For topical (ophthalmic) use only. Instillation of eye drops may
cause transient blurring of vision. Caution should be taken when
driving or operating machinery if blurred vision is experienced
Contraindications
Contraindicated in patients who are hypersensitive to
Olopatadine Hydrochloride or any other component of the
preparation.
Drug interactions
Interactions with other drugs have not been established.
Use in pregnancy and lactation
Pregnancy: There is no adequate and well-controlled studies in
pregnant women. Olopatadine should be used during pregnancy
only if potential benefit justifies the potential risk to the fetus.
Lactation: It is not known whether Olopatadine passes into
breast milk. However, caution should be excercised when
olopatadine is administered to a nursing mother.
Use in pediatric
Safety and effectiveness in children under the age of 3 years
have not been established.
Pharmaceutical precautions
Store at 4° to 30° C temperature. Keep out of the reach of
children. Should be dispensed only on the prescription of a
registered physician. Close the bottle immediately after use. Do
not use for longer than one month after opening the bottle.
Commercial supply
AllelocSterile Eye Drops: Each plastic dropper bottle
contains 5 ml Sterile Eye Drops and an insert.
AllelocDS Sterile Eye Drops: Each plastic dropper bottle
contains 5 ml Sterile Eye Drops and an insert.